Home
Conditions
Hematological Malignancy

Clinical trial condition

Hematological Malignancy

Explore clinical trials studying Hematological Malignancy. Study availability and eligibility vary by location and protocol.

47 public trials 14 recruiting studies

Refine in advanced search Browse all conditions

Hematological Malignancy trial results

Completed

A Study to Compare Forms of Nemtabrutinib (MK-1026) in Healthy Adult Participants (MK-1026-007)

NCT06586671

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancy, +3 more
Locations: QPS-MRA, LLC-Early Phase (Site 0002) South Miami, Florida, United States

View Trial Details

Completed

DxFLEX 10C Clinical Study

NCT05467449

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancy, +3 more
Locations: NeoGenomics Laboratories Aliso Viejo, California, United States

University of Miami Miller School of Medicine Miami, Florida, United States

Quest Diagnostics Lewisville, Texas, United States

PhenoPath Laboratories, PLLC Seattle, Washington, United States

View Trial Details

Completed

Systematic Symptom Identification With Disease Specific PROM to Assess Symptoms of Chronic GVHD in Outpatient Care in Patients Post HSCT

NCT04884204

Conditions: Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +15 more
Locations: Rigshospitalet Copenhagen, Denmark

View Trial Details

Completed

The Effect of Music Therapy on Comfort, Pain and Anxiety

NCT05895357

Conditions: Anxiety Disorders, Bone Marrow Disease, Bone Marrow Diseases, +11 more
Locations: Kayseri City Hospital Kayseri, Turkey (Türkiye)

View Trial Details

Completed

Post-Transplant Bortezomib and High Dose Cyclophosphamide as Graft-Versus-Host Disease (GVHD) Prophylaxis

NCT01860170

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancy, +3 more
Locations: Spectrum Health Grand Rapids, Michigan, United States

View Trial Details

Completed

Use of nMoABs for the Treatment of COVID-19 in Patients With HM.

NCT04932967

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +16 more
Locations: Aou Consorziale Policlinico - Uo Ematologia Con Trapianto Bari, Italy

Asst Degli Spedali Civili Di Brescia Brescia, Italy

Ospedale Valduce - Uos Ematologia Como, Italy

Aou Careggi Florence, Italy

View all 14 locations

View Trial Details

Completed

Prospective Clinical Evaluation of Beta-D-Glucan Assay in Blood and BAL

NCT01576653

Conditions: Bacterial Infections and Mycoses, Hematologic Diseases, Hematologic Neoplasms, +9 more
Locations: Medical University of Graz Graz, Styria, Austria

View Trial Details

Completed

VPA Expanded UCB Transplantation for Treatment of Patients With Hematological Malignancies

NCT03885947

Conditions: Acute Leukemia in Remission, Acute Lymphoblastic Leukemia in Remission, Bone Marrow Diseases, +18 more
Locations: Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details

Completed

Feasibility and Efficacy of Modified Donor Lymphocytes Infusion (CD45RA Negative Selected) After Haploidentical Transplantation With Post-transplantation Cyclophosphamide in Patients With Hematological Malignancies (ONC-2016-002).

NCT04687982

Conditions: Bone Marrow Transplant Complications, Bone Marrow Transplant Infection, Graft vs Host Disease, +9 more
Locations: Istituto Clinico Humanitas Rozzano, MI, Italy

View Trial Details

Completed

Effect of Body Mass on Filgrastim Pharmacokinetics

NCT01719432

Conditions: Agranulocytosis, Body Weight, Cytopenia, +16 more
Locations: West Virginia University Mary Babb Randolph Cancer Center Morgantown, West Virginia, United States

View Trial Details

Hematological Malignancy

Hematological Malignancy trial results

Related conditions